Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Interim Study Results Presented At ADA 2009: Exenatide Not Associated With Increased Rate Of Acute Pancreatitis Compared To Other Antidiabetic Drugs
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced interim results from a retrospective study including nearly 260,000 patients that showed the risk of acute pancreatitis among patients initiating therapy with BYETTA(R) (exenatide) injection was not increased compared to patients initiating other antidiabetic therapies. These findings were presented at the 69th Annual Scientific Sessions of the American Diabetes Association (ADA) in New Orleans.
generic viagra online
Eliminating Polio Requires Global, Coordinated Effort -- Health Affairs Article Highlights Risks, Rewards Of Eradication
Eliminating polio everywhere will require global cooperation on several fronts, including lowering the cost for poor countries to vaccinate with inactivated polio vaccine (IPV), says a leading global health researcher in the July/August Health Affairs thematic issue on global health.
News of the day
World Health Organization Publishes First Indoor Air Quality Guidelines On Dampness And Mould
WHO publishes its first guidelines on indoor air quality, addressing dampness and mould (WHO guidelines on indoor air quality: dampness and mould. Copenhagen, WHO Regional Office for Europe, 2009 (See Here).
Mental Health

Melatonin - The Fountain Of Youth?

Melatonin can slow down the effects of aging. A team at laboratoire Arago in Banyuls sur Mer (CNRS / Universitç© Pierre et Marie Curie) has found that a treatment based on melatonin can delay the first signs of aging in a small mammal. These results appeared in the journal PLoS ONE on 15 June 2009. Better known as the "time-keeping" hormone, melatonin is naturally secreted by the body during the night. It is therefore a kind of biological signal for nightfall, allowing an organism to synchronize itself with the day/night rhythm. At Laboratoire Arago, Elodie Magnanou and her co-workers studied the long-term effects of melatonin on the Greater White-toothed shrew, a small nocturnal insectivorous mammal. Under normal conditions, this animal shows the first signs of aging after reaching 12 months, mainly through the loss of circadian rhythm in its activities. By continuously administering melatonin, starting a little before 12 months, the appearance of these first signs was delayed by at least 3 months, which is a considerable period in relation to the lifespan of this shrew(1). Melatonin is now known to play several beneficial roles. These include being an antioxidant, an anti-depressant, and helping to remediate sleep problems. The next step will be to understand the mode of action of the hormone on aging, so we can perhaps envisage its use on humans. (1)The Greater White-toothed shrew has a lifespan of 12 to 18 months in the wild and up to 30 months in captivity. Captivity does not change the time at which signs of aging appear, it simply lengthens life. Dç©lç©gation Paris Michel-Ange


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009